Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer

被引:23
作者
Obeng-Gyasi, Samilia [1 ]
Li, Yaming [2 ]
Carson, William E. [1 ]
Reisenger, Sarah [3 ]
Presley, Carolyn J. [3 ]
Shields, Peter G. [3 ]
Carbone, David P. [3 ]
Ceppa, DuyKhanh P. [4 ]
Carlos, Ruth C. [5 ]
Andersen, Barbara L. [6 ]
机构
[1] Ohio State Univ, Dept Surg, Div Surg Oncol, 410 W 10th Ave,Room N924 Doan Hall, Columbus, OH 43210 USA
[2] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA
[3] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[4] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
NATIONAL SAMPLE; WOMENS HEALTH; SURVIVAL; SCORE; ADAPTATION; DISEASE; STRESS;
D O I
10.1001/jamanetworkopen.2022.21626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Adverse social determinants of health (SDHs) (eg, poverty) are associated with poor oncologic outcomes among patients with lung cancer. However, no studies have evaluated biological correlates of adverse SDHs, operationalized as allostatic load (AL), with mortality due to lung cancer. OBJECTIVE To examine the association among AL, SDHs, and mortality among patients with metastatic non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study of an observational cohort was performed at a National Cancer Institute-designated comprehensive cancer center with data accrued from June 1, 2017, to August 31, 2019. Patients with metastatic (stage IV) NSCLC enrolled at diagnosis into a prospective observational cohort study were included in the present analysis if they had all the biomarkers to calculate an AL score (N = 143). Follow-up was completed on August 31, 2021, and data were analyzed from July 1 to September 30, 2021. EXPOSURES Social determinants of health. MAIN OUTCOMES AND MEASURES Overall mortality and AL. RESULTS A total of 143 patients met the study criteria with a median age of 63 (IQR, 55-71) years (89 men [62.2%] and 54 women [37.8%]). In terms of race and ethnicity, 1 patient (0.7%) was Asian, 7 (4.9%) were Black, 117 (81.8%) were White, 17 (11.9%) were of multiple races, and 1 (0.7%) was of other race or ethnicity. The mean (SD) AL was 2.90 (1.37). Elevated AL covaried with lower educational level (r = -0.26; P = .002), male sex (r = 0.19; P = .02), limited mobility (r = 0.19; P = .04), worsening self-care (r = 0.30; P < .001), problems engaging in usual activities (r = 0.21; P = .01), depressive symptoms (r = 0.23; P = .005), and a high number of stressful life events (r = 0.30; P < .001). Multivariable analysis found only increasing difficulty with mobility (r = 0.37 [95% CI, 0.13-0.60]; P = .002) and male sex (r = 0.63 [95% CI, 0.19-1.08]; P = .005) associated with higher AL. On adjusted analysis, elevated AL (hazard ratio, 1.43 [95% CI, 1.16-1.79]; P = .001) and low educational level (hazard ratio, 2.11 [95% CI, 1.03-4.34]; P = .04) were associated with worse overall mortality. CONCLUSIONS AND RELEVANCE The findings of this cross-sectional study suggest that higher AL was associated with adverse SDHs and worse overall mortality among patients with advanced NSCLC. These results provide a framework for replication and further studies of AL as a biological correlate for SDH and future prognostic marker.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] OVERALL SURVIVAL AND SMOKING STATUS IN RESECTABLE NON-SMALL CELL LUNG CANCER
    Spain, Lavinia
    Walkiewicz, Marzena
    Knight, Simon
    Mitchell, Paul
    John, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S629 - S629
  • [32] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [33] Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients
    Raez, Luis E.
    Rolfo, Christian
    Mahave, Mauricio
    Caglevic, Christian
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1443 - S1448
  • [34] Circulating Tumor DNA Assay and Survival in Patients with Metastatic, Non-Small Cell Lung Cancer
    Ersek, J.
    Hosking, M.
    Symanowski, J.
    Green, E.
    Zhang, Q.
    Kim, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S663 - S664
  • [35] Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer
    Sun, Haishuang
    Liu, Min
    Yang, Xiaoyan
    Ren, Yanhong
    Dai, Huaping
    Wang, Chen
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (05) : 380 - 393
  • [36] Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients
    Jouinot, Anne
    Ulmann, Guillaume
    Vazeille, Clara
    Durand, Jean-Philippe
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Tlemsani, Camille
    Fournel, Ludovic
    Alifano, Marco
    Wislez, Marie
    Chapron, Jeanne
    Le Bris, Camille
    Mansuet-Lupo, Audrey
    Damotte, Diane
    Neveux, Nathalie
    De Bandt, Jean-Pascal
    Alexandre, Jerome
    Cynober, Luc
    Goldwasser, Francois
    CLINICAL NUTRITION, 2020, 39 (06) : 1893 - 1899
  • [37] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [38] Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer
    Lei, Mingxing
    Liu, Yaosheng
    Tang, Chuanghao
    Yang, Shaoxing
    Liu, Shubin
    Zhou, Shiguo
    BMC CANCER, 2015, 15
  • [39] The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast Cancer
    Chen, J. C.
    Handley, Demond
    Elsaid, Mohamed I.
    Plascak, Jesse J.
    Andersen, Barbara L.
    Carson, William E.
    Pawlik, Timothy M.
    Carlos, Ruth C.
    Obeng-Gyasi, Samilia
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 365 - 375
  • [40] Influence of biological markers on overall survival in surgically treated patients with non-small cell lung cancer
    Loncarevic, Olivera
    Loncarevic, Slobodan
    Vekic, Berislav
    Djukanovic, Leonida
    Vukovic, Jelena
    Rancic, Nemanja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1155 - 1165